Inflammation as a Cardiovascular Risk Factor Are We Ready for Anti-Inflammatory Therapy Review Abstract Inflammation is now firmly established as a central component of atherosclerotic cardiovascular disease and a key contributor to residual cardiovascular risk. While traditional risk factors such as dyslipidemia, hypertension, diabetes mellitus, smoking, and
